Abstract
In an 18-hospital collaborative study, 375 chronic schizophrenics on stable maintenance doses of anti-psychotic drugs were assigned to one of four groups in which medication was withdrawn two or three days a week on varying schedules, or to one in which daily medication was continued. At the end of 16 weeks, there was no significant difference in relapse rate between the continued-treatment and intermittent-treatment groups. That finding suggests that short-term intermittent drug withdrawal is a feasible treatment policy for hospitalized chronic schizophrenics on maintenance chemotherapy. The benefits of a successful intermittent therapy program include less risk of toxicity for the patient; less work for the staff, allowing more time for other therapeutic activities; and lower drug costs for the hospital.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
